6.7(top 2%)
Impact Factor
7.2(top 2%)
extended IF
114(top 3%)
H-Index
1.4K
authors
2.4K
papers
77.3K
citations
5.8K
citing journals
40.5K
citing authors

Most Cited Articles of CNS Drugs

TitleYearCitations
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review2005662
Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention2005522
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy2002463
Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience2002454
Internet addiction: definition, assessment, epidemiology and clinical management2008392
Neuropsychiatric adverse effects of interferon-alpha: recognition and management2005357
Cognitive effects of long-term benzodiazepine use: a meta-analysis2004343
Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence2013329
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia2006315
The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment2003295
Getting into the brain: approaches to enhance brain drug delivery2009294
Suicidal behaviour in bipolar disorder: risk and prevention2003292
Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics2008288
Adverse effects of atypical antipsychotics : differential risk and clinical implications2007286
Smoking cessation in women. Special considerations2001264
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management2010263
Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction2009260
Zolpidem: a review of its use in the management of insomnia2005256
Potential mechanisms of action of lithium in bipolar disorder. Current understanding2013236
Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders2004234
Mechanism of action of St John's wort in depression : what is known?2003234
Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy2008233
Dopamine partial agonists: a new class of antipsychotic2004222
Benzodiazepines and risk of hip fractures in older people: a review of the evidence2003221
Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications2001219